SPOTLIGHT -
Physicians: Still the Vital Connection in Medicine
Jean-Claude Labrune, Chairman & CEO, Cegedim Group
IP: Securing a Global Consensus—Can Industry Do It Again?
Harvey Bale, Jr., MD, former Director-General, IFPMA
Dennis Gillings: Minting the Database
Dennis Gillings, Chairman & CEO, Quintils Transnational Corp.
In Establishing the Evidence Base, He Made Science Count
Robert Seidman, Former Chief Pharmacy Officer, Wellpoint
Jane Henney: Lessons from the FDA Front Line
Jane Henney, MD, Former FDA Commissioner
P. Roy Vagelos: Getting to No. 1—and Staying There
P. Roy Vagelos, MD, Chairman Emeritus, Merck
Francis Collins: Guiding a Revolution in Science
Francis Collins, MD, PhD, Director, National Institutes of Health
Abbey Meyers: The "Mother" of Invention
Abbey Meyers, Founder, National Organization of Rare Disorders
Napoleone Ferrara: Curative Powers of Collaboration
Napoleone Ferrara, MD, PhD, Research Fellow, Genentech
Martin Wygod: Arming up for the Digital Revolution
Martin Wygod, Chairman, WebMD
Candan Carabagli: The East is Up
Candan Karabagli, CEO, Abdi Ibrahim A.S.
Sidney Wolfe: Pharma's Unlikely Best Friend
Sidney Wolfe, MD, Director, Public Citizen's Health Research Group
Peter Piot: The Crisis Manager
Peter Piot, MD, Director, London School of Hygiene and Tropical Medicine
Sir Martin Sorrell: Teamwork and Trust
Sir Martin Sorrell, CEO, WPP
Fernand Sauer: The Essential—and Effective—Bureaucrat
Fernand Sauer, First Director General, European Medicines Agency
Antonio Gotto: Pathfinder in Primary Care
Antonio Gotto, MD, Dean, Weill Cornell Medical College
Productivity, Reputation are Keys to Global Leadership
Yasuchika Hasegawa, President & CEO, Takeda Pharmaceutical Co.
Romania: Staking its Claim
Increasing intergration with the world economy and accession to the Europen Union have been key pillars in talking the growth potential of Romania's pharmaceutical market to greater heights.
Partnering with the New Players
Carlos Morel, MD, Director for Technical Development in Health, Oswaldo Cruz Foundation
Andrew Witty: The Legacy of High Expectations
Andrew Witty, Chairman & CEO, GlaxoSmithKline
Three Decades of Politics and Pop Culture ... on Drugs
Clinical Portals: Balancing Sponsor and Site Perspectives
Pharmaceutical Executive Digital Edition - September 2011
From Many, One
Two Million Man Hours
PricewaterhouseCooper's "Global Construction 2020" report predictions
Pharmaceutical Executive Digital Edition - August 2011
Carrying the Weight of the Future
Can the iPad Save Sales?
What kind of data are iPads collecting? What does physician adoption of iPhones & iPads mean for pharma? Can iPads actually reverse the trend toward shrinking access? Tune in and find out.
Please fill in all required fields for a chance to win a Kindle and to download special advertising information for the Pharmaceutical Executive 30th Anniversary issue.
Pharmaceutical Executive Digital Edition - July 2011
Pedal to the Mettle
Truth Found in the Wrong Places
More bad ideas on how to manage the healthcare burden are circulating beyond the stakeholders that initiated them
Pharma Faceoff
Pharma Faceoff is a video program bringing together key opinion leaders from across the healthcare and pharmaceutical industry to debate the key issues of the day
